Menu Menu

TXG    10x Genomics Inc    1770787    
Income Statement
Revenue 151,654,000
Net Income -35,753,000
Profit Margin -23.58%

Balance Sheet
Current Assets 593,893,000
Assets 937,794,000
Current Liabilities 121,235,000
Liabilities 214,990,000
Equity 722,804,000
Shares Out 106,435,000

Cash Flow Statement
Operating Cash Flow 13,412,000
Investing Cash Flow 18,961,000

Market Analysis
Market Cap 2,608,638,764
Price 15.08
BVPS 6.79
PB 2.21
EPS -2.02
PS 4.30
FCF 32,373,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/15 -0.41
Apr May Jun
4/30 -0.50
Jul Aug Sep
8/08 -0.32
Oct Nov Dec
10/29

Find a discrepancy? The most accurate way to find company fundamental data is to view TXG documents filed with the SEC.


TXG Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: